by Sofia Tzamarelou | Jul 23, 2024 | Blog
Pharma PR and comms need new strategies to reduce the stigma around lung cancer, which gets in the way of screening rates and drug development. Lung cancer has a branding problem More people die from lung cancer than any other cancer, and it kills more women than...
by James Robbins | Jun 17, 2024 | Blog
While energy providers focus on the technical problems around the UK smart meter rollout, they’re failing to address the underlying reasons smart meters face such resistance. The context: Smart meters – electronic devices that record energy consumption...
by Matthew Froggatt | Apr 15, 2024 | Blog
An updated brand shows a new face, a new promise and an indication of real change for a business aiming to thrive in an evolving industry. All brand design work can be dismissed as ‘fluff’ for those who are inclined to think so. But for many who work in marketing,...
by Matthew Couchman | Mar 28, 2024 | Blog
Tech giants’ layoff communications stumbled as they cited economic reasons that were at odds with their record earnings, inadvertently creating reputational risks by igniting concerns over AI’s role in job cuts. What we found: As tech layoff...
by Maya Koleva | Mar 13, 2024 | Blog
Reading time: 3 min As US drug pricing negotiations are making headlines every day, our analysis found that pharma’s reputation is suffering mainly because of media misconceptions that companies can clear out. What we found: Our study of 1,705 English-language...
